IN THE NEWS: Sortilin targeted peptide-drug conjugates – A new mechanism to extend clinical benefit

Pharmacy Times

Ira Winer, M.D., Ph.D., gynecologic oncologist and member of the Gynecologic Oncology and Phase 1 Clinical Trials Multidisciplinary Teams at Karmanos, authors a piece discussing results of the first-in-human trial of sudocetaxel zendusortide, a phase 1 clinical trial that Karmanos participated in.

Read the article here.